American Journal of Kidney Diseases
Volume 51, Issue 1 , Pages 21-28 , January 2008

Metabolic Syndrome and the Development of CKD in American Indians: The Strong Heart Study

  • Jaime Lucove, MSPH

      Affiliations

    • Department of Epidemiology, University of North Carolina-Chapel Hill, NC
    • Corresponding Author InformationAddress correspondence to Jaime C. Lucove, MSPH, Research Scientist, Allscripts, 27 East Delaware Ave, Pennington, NJ.
    • ,
  • Suma Vupputuri, PhD

      Affiliations

    • Department of Epidemiology, University of North Carolina-Chapel Hill, NC
    • University of North Carolina Kidney Center, Chapel Hill, NC
    • ,
  • Gerardo Heiss, MD, PhD

      Affiliations

    • Department of Epidemiology, University of North Carolina-Chapel Hill, NC
    • ,
  • Kari North, PhD

      Affiliations

    • Department of Epidemiology, University of North Carolina-Chapel Hill, NC
    • ,
  • Marie Russell, MD

      Affiliations

    • Medstar Research Institute, Phoenix, AZ.

Received 23 January 2007 ,Accepted 27 September 2007.

References 

  1. US Renal Data System. USRDS Annual Data Report. Bethesda, MD: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2004;
  2. Arias EAR, Kung HC, Murphy SL, Kochanek KD. Deaths: final data for 2001. Natl Vital Stat Rep. 2003;52:1–115
  3. Lee ET, Howard BV, Savage PJ, et al. Diabetes and impaired glucose tolerance in three American Indian populations aged 45-74 years (The Strong Heart Study). Diabetes Care. 1995;18:599–610
  4. Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med. 2003;139:137–147
  5. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41:1–12
  6. Weiner DE, Tighiouart H, Stark PC, et al. Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. Am J Kidney Dis. 2004;44:198–206
  7. Whelton PK, Perneger TV, He J, Klag MJ. The role of blood pressure as a risk factor for renal disease: A review of the epidemiologic evidence. J Hum Hypertens. 1996;10:683–689
  8. Haroun MK, Jaar BG, Hoffman SC, Comstock GW, Klag MJ, Coresh J. Risk factors for chronic kidney disease: A prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol. 2003;14:2934–2941
  9. Brancati FL, Whelton PK, Randall BL, Neaton JD, Stamler J, Klag MJ. Risk of end-stage renal disease in diabetes mellitus: A prospective cohort study of men screened for MRFIT (Multiple Risk Factor Intervention Trial). JAMA. 1997;278:2069–2074
  10. Muntner P, Coresh J, Smith JC, Eckfeldt J, Klag MJ. Plasma lipids and risk of developing renal dysfunction: The Atherosclerosis Risk in Communities Study. Kidney Int. 2000;58:293–301
  11. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: Findings from the Third National Health and Nutrition Examination Survey. JAMA. 2002;287:356–359
  12. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486–2497
  13. Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol. 2005;16:2134–2140
  14. Bonnet F, Marre M, Halimi JM, et al. DESIR Study Group Waist circumference and the metabolic syndrome predict the development of elevated albuminuria in non-diabetic subjects: The DESIR Study. J Hypertens. 2006;24:1157–1163
  15. Hoehner CM, Greenlund KJ, Rith-Najarian S, Casper ML, McClellan WM. Association of the insulin resistance syndrome and microalbuminuria among nondiabetic native Americans (The Inter-Tribal Heart Project). J Am Soc Nephrol. 2002;13:1626–1634
  16. Chen J, Muntner P, Hamm LL, et al. The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med. 2004;140:167–174
  17. Chen J, Muntner P, Hamm LL, et al. Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol. 2003;14:469–477
  18. Lee ET, Welty TK, Fabsitz R, et al. The Strong Heart Study (A study of cardiovascular disease in American Indians: Design and methods). Am J Epidemiol. 1990;132:1141–1155
  19. Welty TK, Lee ET, Yeh J, et al. Cardiovascular disease risk factors among American Indians (The Strong Heart Study). Am J Epidemiol. 1995;142:269–287
  20. Howard BV, Lee ET, Cowan LD, et al. Coronary heart disease prevalence and its relation to risk factors in American Indians (The Strong Heart Study). Am J Epidemiol. 1995;142:254–268
  21. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2004;27(suppl 1):S5–S10
  22. Resnick HE, Jones K, Ruotolo G, et al. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic American Indians: The Strong Heart Study. Diabetes Care. 2003;26:861–867
  23. The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 1993;153:154–183
  24. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care. 2003;26(suppl 1):S33–S50
  25. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation (Modification of Diet in Renal Disease Study Group). Ann Intern Med. 1999;130:461–470
  26. Alberti KG, Zimmet P, Shaw J IDF Epidemiology Task Force Consensus Group. The metabolic syndrome—A new worldwide definition. Lancet. 2005;366:1059–1062
  27. Nelson RG, Bennett PH, Beck GJ, et al. Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus (Diabetic Renal Disease Study Group). N Engl J Med. 1996;335:1636–1642
  28. Nelson RG, Newman JM, Knowler WC, et al. Incidence of end-stage renal disease in type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians. Diabetologia. 1988;31:730–736
  29. Nelson RG, Kunzelman CL, Pettitt DJ, Saad MF, Bennett PH, Knowler WC. Albuminuria in type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance in Pima Indians. Diabetologia. 1989;32:870–876
  30. Tapp RJ, Shaw JE, Zimmet PZ, et al. Albuminuria is evident in the early stages of diabetes onset: Results from the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Am J Kidney Dis. 2004;44:792–798
  31. Sosenko JM, Hu D, Welty T, Howard BV, Lee E, Robbins DC. Albuminuria in recent-onset type 2 diabetes: The Strong Heart Study. Diabetes Care. 2002;25:1078–1084
  32. Spijkerman AM, Dekker JM, Nijpels G, et al. Microvascular complications at time of diagnosis of type 2 diabetes are similar among diabetic patients detected by targeted screening and patients newly diagnosed in general practice: The Hoorn Screening Study. Diabetes Care. 2003;26:2604–2608
  33. Kohler KA, McClellan WM, Ziemer DC, Kleinbaum DG, Boring JR. Risk factors for microalbuminuria in black Americans with newly diagnosed type 2 diabetes. Am J Kidney Dis. 2000;36:903–913
  34. Sonnenberg GE, Krakower GR, Kissebah AH. A novel pathway to the manifestations of metabolic syndrome. Obes Res. 2004;12:180–186
  35. Feldt-Rasmussen B. Microalbuminuria, endothelial dysfunction and cardiovascular risk. Diabetes Metab. 2000;26(suppl 4):S64–S66
  36. Greenberg AS. The expanding scope of the metabolic syndrome and implications for the management of cardiovascular risk in type 2 diabetes with particular focus on the emerging role of the thiazolidinediones. J Diabetes Complications. 2003;17:218–228
  37. Kambham N, Markowitz GS, Valeri AM, Lin J, D’Agati VD. Obesity-related glomerulopathy: An emerging epidemic. Kidney Int. 2001;59:1498–1509
  38. Hall JE, Crook ED, Jones DW, Wofford MR, Dubbert PM. Mechanisms of obesity-associated cardiovascular and renal disease. Am J Med Sci. 2002;324:127–137
  39. Cirillo P, Sato W, Reungjui S, et al. Uric acid, the metabolic syndrome, and renal disease. J Am Soc Nephrol. 2006;17(suppl 3):S165–S168
  40. Nelson RG, Beck GJ, et al. Estimating GFR by the MDRD and Cockroft-Gault Equations in Pima Indians. GT J Am Soc Nephrol. 2003;14:134A;(abstr)
  41. Perkins BA, Nelson RG, Ostrander BE, et al. Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: Results of a 4-year follow-up study. J Am Soc Nephrol. 2005;16:1404–1412

 Originally published online as doi:10.1053/j.ajkd.2007.09.014 on November 28, 2007.This work was performed at the University of North Carolina-Chapel Hill and all Strong Heart Study Centers: Medstar Research Institute, Aberdeen Area Indian Health Service, Aberdeen Area Tribal Chairmen’s Health Board, Center for American Indian Health Research, and University of Oklahoma Health Sciences Center.

PII: S0272-6386(07)01309-1

doi: 10.1053/j.ajkd.2007.09.014

American Journal of Kidney Diseases
Volume 51, Issue 1 , Pages 21-28 , January 2008

Article Tools